TB-500 from Super Human Peptides UK is a synthetic version of the naturally occurring peptide Thymosin Beta-4 (Tβ4). It is a highly conserved, 43-amino acid sequence that is present in almost all animal and human cells, with particularly high concentrations found in blood platelets and wound fluid. In laboratory research, TB-500 is a premier model for investigating profound systemic tissue repair, cellular migration, and angiogenesis.
Researchers utilize this peptide to study its primary mechanism of action: the upregulation of cell-building proteins such as actin. By binding to actin, TB-500 promotes the rapid migration of healing cells to sites of tissue damage, facilitating accelerated repair in muscle, tendon, ligament, and even cardiac tissues. Produced under GMP-compliant conditions and verified for 99% purity or higher, TB-500 is a cornerstone compound for advanced regenerative medicine and wound-healing models.
- —Actin Sequestering: Binds to actin to govern cell structure, motility, and rapid cellular migration to injury sites.
- —Angiogenesis Modulator: Stimulates the formation of new blood vessels to supply oxygen and nutrients to damaged tissue.
- —Systemic Circulation: Its low molecular weight allows it to travel freely through the body to locate target areas of inflammation and injury.
- —High Purity: 99% purity or higher (verified by HPLC and MS analysis).
- —Quality Standard: GMP / ISO certified manufacturing.
- —Documentation: Full Certificate of Analysis (COA) included with every batch.
- —Cellular Migration: Studying the peptide's ability to alter the cellular cytoskeleton and direct the movement of macrophages and endothelial cells to injury sites.
- —Angiogenesis and Vascular Repair: Researching the induction of VEGF (Vascular Endothelial Growth Factor) to create new capillary networks.
- —Cardiac Regeneration: Preclinical models investigating the survival and repair of myocardium (heart muscle) following ischemic injury or induced myocardial infarction.
- —Soft Tissue Repair: Evaluating accelerated healing rates in models of severe skeletal muscle trauma, tendon ruptures, and ligament damage.
- —Corneal Healing: Investigating the rapid repair of epithelial defects and the reduction of inflammation in ophthalmologic models.
Thymosin Beta-4 was first identified by researchers in the 1980s when exploring the immune-regulating properties of the thymus gland. However, subsequent laboratory studies revealed that its primary function lies in tissue repair via actin sequestration. Research by Philp et al.
demonstrated that Tβ4 acts as a major actin-sequestering molecule, maintaining a pool of unpolymerized actin that cells can rapidly deploy to change shape and move across tissue matrices to repair wounds. Furthermore, animal models have shown that TB-500 administration drastically reduces scar tissue formation (fibrosis) while simultaneously creating new blood vessels to nourish the regenerating tissue. Because of its profound regenerative properties across almost all tissue types (including neural, cardiac, and musculoskeletal), it remains one of the most thoroughly documented tissue-repair peptides in scientific literature.
- 1.Goldstein, A.L. et al., "Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues," Trends in Molecular Medicine, 2012.
- 2.Philp, D. et al., "Thymosin beta4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice," Wound Repair and Regeneration, 2003.
- 3.Smart, N. et al., "Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization," Nature, 2007.
- 4.Sosne, G. et al., "Thymosin beta4 promotes corneal wound healing and modulates inflammatory mediators in vivo," Experimental Eye Research, 2002.
